RecallReported October 28, 2026

Class II recall by AvKARE

Amitriptyline Hydrochloride, Tablets, USP, 10 mg, 5 x 10 Unit dose cards in paper cartons, Rx only, Manufactured for AvKARE, Pulaski, TN 384…

FDA's record ↗

FDA's enforcement report of October 28, 2026 lists a Class II recall by AvKARE of Pulaski, TN. Product: Amitriptyline Hydrochloride, Tablets, USP, 10 mg, 5 x 10 Unit dose cards in paper cartons, Rx only, Manufactured for AvKARE, Pulaski, TN 384…. Status: Ongoing.

On the record

Recalling firm
AvKARE
Location
Pulaski, TN
Classification
Class II
Status
Ongoing
Product type
Drugs
Brand names
AMITRIPTYLINE HYDROCHLORIDE
Generic names
AMITRIPTYLINE HYDROCHLORIDE
Recall initiated
2026-10-02
Reported by FDA
2026-10-28
Source
FDA enforcement reports ↗

The full record

An account shows the reason for the recall, where the product was distributed and the lots.

What a recall is

FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.

More

Watch AvKARE

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA enforcement reports. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with AvKARE.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.